Feds Say Pharma Cos. Can't Win Medicare Drug Price Suit
By Mark Payne · November 30, 2023, 7:23 PM EST
The federal government told a D.C. federal court that it shouldn't issue Merck & Co. Inc.'s summary judgment in its lawsuit challenging the Inflation Reduction Act's Medicare drug price negotiation program,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login